Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 49, Issue 5, 2009, Pages 599-606

  Rubio, Amandine ^a   Monpoux, Fabrice ^b   Huguon, Emilie ^b   Truchi, Régine ^b   Triolo, Valérie ^b   Rosenthal Allieri, Maria Alessandra ^b   Deville, Anne ^b   Rosenthal, Eric ^a   Boutté, Patrick ^a   Tran, Albert ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Antiretroviral therapy; FibroTest; Hepatotoxicity; HIV 1; Transient elastography.

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; EFAVIRENZ; LAMIVUDINE; LIVER ENZYME; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; LIVER TOXICITY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SCHOOL CHILD; ULTRASOUND; VERTICAL TRANSMISSION; VIRUS LOAD;

ADOLESCENT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DRUG-INDUCED LIVER INJURY; FATTY LIVER; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LIVER; MALE; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350627280     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181a15b72     Document Type: Article

References (59)

1. Chiappini E, Galli L, Tovo PA, et al. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS 2007;21:1607-1615
2. Patel K, Hernán MA, Williams PL, et al., Pediatric AIDS Clinical Trials Group 219/219C Study Team. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008;46:507-515 (Pubitemid 351263487)
3. Judd A, Doerholt K, Tookey PA, et al., Collaborative HIV Paediatric Study (CHIPS); National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007;45:918-924
4. McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS 2004;18:1753-1768
5. McComsey GA, O'Riordan M, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007;21:921-927
6. Fine DM, Atta MG. Kidney disease in the HIV-infected patient. AIDS Patient Care STDS 2007;21:813-824
7. Hooshyar D, Hanson DL, Wolfe M, et al. Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS 2007;21:2093-2100
8. Pol S, Lebray P, Vallet-Pichard A. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clin Infect Dis 2004;38 (Suppl 2):65-72.
9. Soriano V, Puoti M, Garcia-Gasco P, et al. Antiretroviral drugs and liver injury. AIDS 2008;22:1-13.
10. Soriano V, Rodríguez-Rosado R, García-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS 1999; 13:539-546
11. Rosenthal E, Poirée M, Pradier C, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003;17:1803-1809.
12. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 1990; 12:505-510
13. Cribier B, Schmitt C, Rey D, et al. Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV. Res Virol 1996;147:263-266
14. Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev 2003;5:36-43.
15. Loulergue P, Callard P, Bonnard P, et al. Hepatic steatosis as an emerging cause of cirrhosis in HIV-infected patients. J Acquir Immune Defic Syndr 2007;45:365.
16. Starr SE, Fletcher CV, Spector SA, et al. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med 1999;341:1874-1881
17. Mofenson LM, Korelitz J, Meyer WA 3rd et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Infect Dis 1997;175:1029-1038
18. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337-1342
19. Jullien V, Raïs A, Urien S, et al. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis. Br J Clin Pharmacol 2007;64:105-109
20. Chadwick EG, Capparelli EV, Yogev R, et al. P1030 team Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS 2008; 22:249-255
21. Lacaille F, Fournet JC, Blanche S. Clinical utility of liver biopsy in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1999;18:143-147
22. Thuret I, Lacaille F, Canioni D, et al. Histopathology of the liver in adolescents co-infected with HIV and hepatitis C virus. AIDS 2003;17:2265-2267
23. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
24. Friedman LS. Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep 2004;6:30-36
25. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457 (Pubitemid 37466971)
26. Stanley AJ, Haydon GH, Piris J, et al. Assessment of liver histology in patients with hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol 1996;8:869-872
27. Bonnard P, Lescure FX, Amiel C, et al. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count. J Viral Hepat 2007; 14:806-811
28. Poynard T, Imbert-Bismut F, Ratziu V, et al., GERMED cyt04 groupBiochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-133
29. Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8.
30. Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005;4:10.
31. Ngo Y, Munteanu M, Messous D, et al. A prospective analysis of the prognostic value of Biomarkers (FibroTest) in patients with Chronic Hepatitis C. Clin Chem 2006;52:1887-1896.
32. Shaheen AA, Myers RP. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection. HIV Clin Trials 2008;9:43-51.
33. Nunes D, Fleming C, Offner G, et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 2005;40:538-544
34. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-992
35. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526
36. Toniutto P, Fabris C, Falleti E, et al. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 2007;22:1904-1908
37. Fabris C, Smirne C, Toniutto P, et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem 2006;39:339-343
38. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713
39. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.
40. de Lédinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparisonwith FibroTest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-450
41. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835-847
42. Lansky SB, List MA, Lansky LL, et al. The measurement of performance in childhood cancer patients. Cancer 1987;60:1651-1656
43. Schneider E, Whitmore S, Glynn KM, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged
44. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004; 18:1443-1451.
45. Poles MA, Dieterich DT, Scharz ED, et al. Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV). J Acquir Immune Defic Syndr Hum Retrovirol 1986;11:170-177
46. Nesheim SR, Kapogiannis BG, Soe MM, et al. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Pediatrics 2007; 120:100-109
47. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-2009
48. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393
49. Gil AC, Lorenzetti R, Mendes GB, et al. Hepatotoxicity in HIVinfected children and adolescents on antiretroviral therapy. Sao Paulo Med J 2007;125:205-209
50. D'Onofrio M, Martone E, Brunelli S, et al. Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. Radiol Med 2005;110:341-348
51. Núñez M, Soriano V. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. Drug Saf 2005;28:53-66.
52. Abrescia N, D'Abbraccio M, Figoni M, et al. Hepatotoxicity of antiretroviral drugs. Curr Pharm Des 2005;11:3697-3710
53. Dore G. Antiretroviral therapy-related hepatotoxicity: predictors and clinical management. J HIV Ther 2003;8:96-100.
54. Kontorinis N, Dieterich DT. Toxicity of non-nucleoside analogue reverse transcriptase inhibitors. Semin Liver Dis 2003; 23:173-182
55. Cooper CL, Parbhakar MA, Angel JB. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2002;34:1259-1263
56. de Franchis R, Dell'era A, Primignani M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis 2008;40:312-317
57. Castellares C, Barreiro P, Martín-Carbonero L, et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat 2008;15:165-172
58. Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Noninvasive, quantitative assessment of liver fibrosis. Hepatol Res 2007;37:1002-1010
59. Roulot D, Czernichow S, Le Clésiau H, et al. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol 2008;48:606-613